Send me real-time posts from this site at my email
Zacks

CME Group (CME) to Report Q2 Earnings: What's in the Cards?

CME Group CME is slated to report second-quarter 2021 results on Jul 28, before market open. The company delivered an earnings surprise of 2.29% in the last reported quarter.

Factors to Consider

CME Group’s second-quarter revenues are likely to have been affected by lower clearing and transaction fees and other revenues, partially offset by higher market data and information services.

The Zacks Consensus Estimate for clearing and transaction fees is pegged at $917 million, indicating a decrease of 2.4% from the year-ago reported figure.

Decrease in cash markets business, lower fixed income volume and foreign exchange volume, decrease in processing services revenues and custody fees are likely to have hurt the top-line growth. However, the downside is likely to be partially offset by market data and information services revenues owing to price increases for certain products.

The Zacks Consensus Estimate for the top line is pegged at $1.1 billion, indicating a decline of 1% from the year-ago reported figure.

Recently, CME Group reported decent average daily volume (ADV) for the second quarter. ADV of 18.4 million contracts per day improved 5% year over year in the second quarter due to increased volumes in four of the six product lines.

Interest rate volume of 8.8 million contracts per day increased 25% while Foreign exchange volumes increased 6% to about 0.8 million contracts per day. Metals volume of 0.6 million contracts per day grew 9%. Moreover, Agricultural volume of 1.6 million contracts per day increased 24%. However, Energy volume of about 2 million contracts declined 24% year over year while Equity index volume of nearly 5 million contracts per day fell 12%.

Higher compensation and benefits, technology, depreciation and amortization expenses are likely to have increased expenses in the second quarter.

The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $1.59, indicating a decrease of 2.45% from the year-ago quarter reported figure.

What the Zacks Model Says

Our proven model does not conclusively predict an earnings beat for CME Group this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case as you can see below.

Earnings ESP: CME Group has an Earnings ESP of 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $1.59. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

CME Group Inc. Price and EPS Surprise

Zacks Rank: CME Group currently carries a Zacks Rank of 3.

Stocks to Consider

Some finance stocks with the right combination of elements to come up with an earnings beat this time around are:

Coinbase Global, Inc. COIN has an Earnings ESP of +6.64% and a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Alliance Data Systems Corporation ADS has an Earnings ESP of +3.13% and a Zacks Rank #3.

Equifax, Inc. EFX has an Earnings ESP of +0.48% and a Zacks Rank of 2.


Time to Invest in Legal Marijuana

If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.

After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.

You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.

Today, Download Marijuana Moneymakers FREE >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CME Group Inc. (CME): Free Stock Analysis Report
 
Alliance Data Systems Corporation (ADS): Free Stock Analysis Report
 
Equifax, Inc. (EFX): Free Stock Analysis Report
 
Coinbase Global, Inc. (COIN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue